Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial - Keystone, EC; Kavanaugh, AF; Sharp, JT (Arthritis Rheum, 2004)
et al.